0
0
Read Time:9 Second
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled “Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %